Work

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Year: 2002

Type: article

Study design: Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(02)08089-3

Authors: Björn Dahlöf, Richard B Devereux, Sverre E Kjeldsen, Stevo Julius, Gareth Beevers, Ulf de Faire, Frej Fyhrquist, Hans Ibsen, Krister Kristiansson, Ole Lederballe-Pedersen, Lars H Lindholm, Markku S Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel

Institutions: Sahlgrenska University Hospital, Oslo University Hospital, University of Michigan, Birmingham City Hospital, Karolinska University Hospital, Helsinki University Hospital, Glostrup Hospital, Regionshospitalet Viborg, Umeå University, Haukeland University Hospital, University of Alabama at Birmingham, Nordic School of Public Health

Language: English

Topic: Blood Pressure and Hypertension Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2133217116

FWCI: 317

Cites: 29

Cited by: 5,427

Related to: 10